BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 11985000)

  • 21. [Early control of diabetic sequelae. Combined insulin treatment also in type 2].
    MMW Fortschr Med; 2000 Jun; 142(25):57. PubMed ID: 10920674
    [No Abstract]   [Full Text] [Related]  

  • 22. A dose range finding study of novel oral insulin (IN-105) under fed conditions in type 2 diabetes mellitus subjects.
    Khedkar A; Iyer H; Anand A; Verma M; Krishnamurthy S; Savale S; Atignal A
    Diabetes Obes Metab; 2010 Aug; 12(8):659-64. PubMed ID: 20590742
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Thiazolidinediones--a new class of oral antidiabetics].
    Schmitz OE; Brock B; Madsbad S; Beck-Nielsen H
    Ugeskr Laeger; 2001 Oct; 163(44):6106-11. PubMed ID: 11715152
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Therapy of type 2 diabetes. Critical evaluation of oral antidiabetic drugs].
    Landgraf R
    MMW Fortschr Med; 2000 May; 142(21):33-7. PubMed ID: 10872292
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Managing therapy and adverse effects with antihyperglycemic agents: a focus on metformin and acarbose.
    Phillips BB
    Pharm Pract Manag Q; 1997 Oct; 17(3):21-31. PubMed ID: 10173308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined effects of atorvastatin and metformin on glucose-induced variations of inflammatory process in patients with diabetes mellitus.
    Tousoulis D; Koniari K; Antoniades C; Papageorgiou N; Miliou A; Noutsou M; Nikolopoulou A; Marinou K; Stefanadi E; Siasos G; Charakida M; Kamboli AM; Stefanadis C
    Int J Cardiol; 2011 May; 149(1):46-9. PubMed ID: 20034685
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Type II diabetes: how to use the new oral medications. Interview by David B. Jack.
    Bohannon NJ
    Geriatrics; 1996 Apr; 51(4):33-7. PubMed ID: 8626076
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Continuation of metformin after introduction of insulin in type 2 diabetes.
    Kooy A
    BMJ; 2009 Nov; 339():b4227. PubMed ID: 19900992
    [No Abstract]   [Full Text] [Related]  

  • 29. [Management of diabetes in general practice--current requirements. 2: Oral antidiabetics and insulin therapy].
    Mehnert H
    Fortschr Med; 1994 Apr; 112(12):163-6. PubMed ID: 8200602
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Type 2 diabetes. Regulating insulin according to need].
    MMW Fortschr Med; 2001 Oct; 143(42):62. PubMed ID: 11697294
    [No Abstract]   [Full Text] [Related]  

  • 31. Metformin use in patients with diabetes mellitus and heart failure: friend or foe?
    Giamouzis G; Triposkiadis F; Butler J
    J Card Fail; 2010 Mar; 16(3):207-10. PubMed ID: 20206894
    [No Abstract]   [Full Text] [Related]  

  • 32. [The effect of metformin on late diabetic complications and cardiovascular events in obese patients with type 2 diabetes].
    Christiansen AL; Madsbad S
    Ugeskr Laeger; 2002 Apr; 164(15):2022-4. PubMed ID: 11984999
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metformin: an alternative treatment for noninsulin-dependent diabetes mellitus.
    Hitt CM
    Conn Med; 1995 Dec; 59(12):727-30. PubMed ID: 8821636
    [No Abstract]   [Full Text] [Related]  

  • 34. Beyond metformin: initiating combination therapy in patients with type 2 diabetes mellitus.
    Goldman-Levine JD
    Pharmacotherapy; 2011 Dec; 31(12 Suppl):44S-53S. PubMed ID: 22122222
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Membrane physiology as a basis for the cellular effects of metformin in insulin resistance and diabetes.
    Wiernsperger NF
    Diabetes Metab; 1999 Jun; 25(2):110-27. PubMed ID: 10443322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Primary prevention of diabetes mellitus by pharmacological intervention].
    Noda M
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():100-8. PubMed ID: 12386980
    [No Abstract]   [Full Text] [Related]  

  • 37. [Formulation by design of experiments of immediate release tablets with metformin hydrochloride and glibenclamide].
    Potur RG; GafiĊ£anu E
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(4):1219-26. PubMed ID: 21500483
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Better blood glucose control. Extending metformin dosage].
    MMW Fortschr Med; 2001 Sep; 143(38):59. PubMed ID: 11601099
    [No Abstract]   [Full Text] [Related]  

  • 39. Saxagliptin/metformin (kombiglyze XR) for type 2 diabetes.
    Med Lett Drugs Ther; 2011 Mar; 53(1360):21-2. PubMed ID: 21412207
    [No Abstract]   [Full Text] [Related]  

  • 40. [Hypoglycemia].
    Gupta PS; Green AN; Chowdhury TA
    Praxis (Bern 1994); 2011 Oct; 100(21):1303-5. PubMed ID: 22012756
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.